STLR Link Roundup – April 26, 2019

“Facebook Investigated in Ireland Over Mishandled Passwords” The Irish Data Protection Commission announced on Thursday, April 25, 2019 that an investigation has been opened by an Irish data regulator into Facebook’s mishandling of passwords for millions of users. Facebook commented on the alleged mishandling passwords in March, saying that it did not “properly mask” passwords for many of its users, instead storing the passwords as plain text in an internal database that Facebook’s staff had Continue Reading →

STLR Link Roundup – April 25, 2019

“Tech and Privacy Groups Hate the Census Citizenship Question” Although business leaders in the tech industry and prominent privacy advocates usually stay on opposite sides of the aisle, the Trump administration’s attempt to add a citizenship question to the 2020 census has these players on the same team. Both groups filed (separate) amicus briefs to the Supreme Court in advance of oral argument on the issue, which took place on Tuesday, April 23, 2019. Privacy Continue Reading →

STLR Link Roundup – April 9, 2019

Proposed Amendment to the CCPA Would Create a Private Right of Action for All Violators After the enactment of the GDPR in May 2018, the California Consumer Privacy Act of 2018 was a “first-in-the-nation regulatory overhaul” for data protection. “The CCPA expanded consumer data protection laws by requiring large businesses operating in California to, among other things, notify their customers about the nature of their data collection (including what type of data is being collected Continue Reading →

STLR Link Roundup – April 6, 2019

Federal Circuit Agrees Purdue’s OxyContin Anti-Tampering Patent Is Obvious On April 4, 2019, the U.S. Court of Appeals for the Federal Circuit affirmed a November 2017 decision of the Patent Trial and Appeal Board (PTAB) invalidating a Purdue Pharma LP patent covering a way to make its OxyContin painkiller resistant to abuse. According to Purdue, the patent covered the use of a hot-melt extrusion process which yielded a “core matrix” of magnesium stearate, oxycodone, and Continue Reading →

STLR Link Roundup – March 15, 2019

The Apple-Qualcomm Patent Battle On March 15, 2019, the jury of the federal District Court for the Southern District of California found that Apple infringed on three patents of Qualcomm and was required to compensate Qualcomm $1.41 per infringing iPhone sold. Specifically, the court found that Apple’s iPhone 7, 7 Plus, 8, 8 Plus and X have infringed Qualcomm’s two U.S. patents, 8,838,949 and 9,535,490. Also, Apple’s iPhone 8, 8 Plus and X have infringed Continue Reading →

STLR Link Roundup – March 5, 2019

High Court Limit On Costs In Copyright Cases Clarifies Stakes In a U.S. Supreme Court decision on March 4, 2019, the court ruled that “a federal district court’s discretion to award ‘full costs’ to a party in copyright litigation is limited to the six categories specified in the general costs statute.” In the case Rimini Street Inc. v. Oracle USA Inc., the District Court awarded Oracle fees and costs, including $12.8 million for litigation expenses Continue Reading →

STLR Link Roundup – February 26, 2019

British Parliamentary Committee Urges Rgulation on the Technology Industry On February 18th, 2019 a scathing report by a British parliamentary committee was published urging tougher rules to keep technology companies in check.  In this report, they stated that Facebook “misled” Parliament on data misuse.  They also argued that “companies like Facebook should not be allowed to behave like digital gangsters.”  This report was released after 18 months of investigating Facebook and contributes to the growing Continue Reading →

STLR Link Roundup – February 15, 2019

Eligibility of Medical Diagnostics Method to be Patented On February 6, 2019, the U.S. Court of Appeals for the Federal Circuit ruled that the medical diagnostics method at hand were patent ineligible under 35 U.S.C. § 101. Plaintiff, Athena Diagnostics, Inc., was the exclusive licensee of the patent that covered “methods for diagnosing neurological disorders by detecting antibodies to a protein.” After Defendant, Mayo Collaborative Services, LLC, allegedly exercised the patent for developing other competing Continue Reading →

STLR Link Roundup – February 8, 2019

Progress in Pharmaceutical Pricing via Rebates On January 31st, 2019, the Office of the Inspector General and Department of Health and Human services proposed a rule to lower prescription drug prices by removing the safe harbor under the Anti-Kickback statutes of rebates paid by manufacturers to pharmacy benefit managers, part D plans, and Medicaid managed care organizations. It creates a new safe harbor for discounts that are offered directly to patients and fixed fee service arrangements Continue Reading →

STLR Link Roundup – February 1, 2019

Apple Turns to Self-Help to Punish Violators of Developer Policies Regarding Personal Data This week, Apple suspended internal apps used by both Google and Facebook employees on Apple’s iOS operating system after acknowledgement that Google and Facebook independently used these internal apps to gather data on internet use from consumer volunteers. Apple has since restored the apps on Apple devices. This approach has highlighted the lengths Apple is willing to go to protect user information, Continue Reading →